Current Treatment of Alopecia Areata

Research output: Contribution to journalComment/debatepeer-review


The number of alopecia areata (AA) clinical trials with Jak inhibitors of cytoplasmic tyrosine kinases, including Jak1, Jak2, Jak3, and tyrosine-protein kinase has increased significantly since the last Research Summit. This fact means that the conversation about current treatments for AA now also needs to include a discussion of traditionally used off-label therapies as well as evolving therapies as with Jak inhibitors.

Original languageEnglish (US)
Pages (from-to)S28-S30
JournalJournal of Investigative Dermatology Symposium Proceedings
Issue number1
StatePublished - Nov 2020

Bibliographical note

Publisher Copyright:
© 2020 The Author


Dive into the research topics of 'Current Treatment of Alopecia Areata'. Together they form a unique fingerprint.

Cite this